Cytovance Biologics Launches Cell Line Development Services for Mammalian Programs

Scinai Immunotherapeutics Reports Q1 2026 Results Following Recipharm Israel Deal

Symeres Expands Spray Drying Capabilities at New Jersey CMC Site

Axplora Consolidates UDCA Manufacturing at Vizag Site by End of 2026

Chime Biologics Expands Manufacturing Capacity With New GMP-2 Facility

Chime Biologics Partners With Daewoong Pharmaceutical on Dupilumab Biosimilar

Matica Biotechnology Partners With UHN on IL-10 Adenoviral Gene Therapy Manufacturing

VIVEbiotech Expands In Vivo Gene Therapy Portfolio to 15 Programs

Gaelic Laboratories Completes Phase 1 Integration With Athlone Laboratories